LON:GENF Genflow Biosciences (GENF) Share Price, News & Analysis GBX 1.94 +0.06 (+3.20%) As of 07:15 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsNews and Trends About Genflow Biosciences Stock (LON:GENF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Genflow Biosciences alerts:Sign Up Key Stats Today's Range 1.90▼ 1.9950-Day Range 1.63▼ 2.4652-Week Range 0.90▼ 3.12Volume1.42 million shsAverage Volume2.17 million shsMarket Capitalization£10.96 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs. The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results. Read More Receive GENF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genflow Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GENF Stock News HeadlinesSIRT6 gene therapy shows promise in aged dogs - ICYMIJune 27, 2026 | uk.finance.yahoo.comGenflow Biosciences PLC Announces Participation at BIO International Convention 2026June 22, 2026 | finance.yahoo.comShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he says has never existed before. In a similar setup in the past, select investors saw $1,000 turn into over $1 million within a few years. Del Real just released a full video breakdown of what is driving this move and how to prepare.September 24 at 1:00 AM | Digest Publishing (Ad)Genflow CEO on showcasing dog longevity gene therapy results at Toronto summitJune 22, 2026 | finance.yahoo.comGenflow Biosciences PLC - Company to present at Animal Longevity Summit 2026June 17, 2026 | finance.yahoo.comGenflow Biosciences PLC Announces Notice of AGMJune 5, 2026 | finance.yahoo.comGenflow Biosciences PLC Announces Exercise of Warrants and Issue of EquityMay 8, 2026 | finance.yahoo.comGenflow Biosciences PLC Announces Final ResultsMay 1, 2026 | finance.yahoo.comSee More Headlines GENF Stock Analysis - Frequently Asked Questions How have GENF shares performed this year? Genflow Biosciences' stock was trading at GBX 1.85 at the beginning of the year. Since then, GENF shares have increased by 2.4% and is now trading at GBX 1.89. How were Genflow Biosciences' earnings last quarter? Genflow Biosciences plc (LON:GENF) released its earnings results on Thursday, April, 30th. The company reported ($0.33) EPS for the quarter. Genflow Biosciences had a positive trailing twelve-month return on equity of 332.06% and a negative net margin of 170.64%. How do I buy shares of Genflow Biosciences? Shares of GENF stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Genflow Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genflow Biosciences investors own include Aehr Test Systems (AEHR), Advanced Micro Devices (AMD), ARM (ARM), NIO (NIO), NVIDIA (NVDA) and PayPal (PYPL). Company Calendar Last Earnings4/30/2026Today9/24/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolLON:GENF CIKN/A Webgenflowbio.com Phone44 32 4774 95881FaxN/AEmployees5Year FoundedN/AProfitability EPS (Trailing Twelve Months)GBX (0.33) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-£1.76 million Net Margins-170.64% Pretax MarginN/A Return on Equity332.06% Return on Assets-58.66% Debt Debt-to-Equity RatioN/A Current Ratio0.45 Quick Ratio20.20 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.65 per share Price / Cash Flow3.00 Book ValueGBX 0.25 per share Price / Book7.80Miscellaneous Outstanding Shares566,410,000Free FloatN/AMarket Cap£10.96 million OptionableNot Optionable Beta2.29 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (LON:GENF) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersEveryone remembers January's silver spike. Then what?Silver is up more than 50 percent over the past year, yet interest has faded since its January record. The ...i2i Marketing Group, LLC | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredWhile SpaceX Gets the Spotlight, FJET Is Building What Comes Next!Starfighters Space (NYSE: FJET) operates the world's only commercial fleet of flight-ready Mach 2+ F-104 Starf...Trading Wire | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | SponsoredThey're shrinking your dollars every single monthSince 2020, the dollar has lost roughly a quarter of its buying power. A $500,000 nest egg today buys about wh...American Alternative | SponsoredWhy I believe the AI market will split in Q4Matt McCall, who recommended Nvidia near $6 a share, says the AI market is splitting in two - just like the do...The Oxford Club | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genflow Biosciences plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genflow Biosciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
